Company Filing History:
Years Active: 2004-2010
Title: Judith Dierlamm: Innovator in Molecular Characterization
Introduction
Judith Dierlamm is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of molecular characterization, particularly in relation to chromosome translocations and their implications in carcinogenesis. Her work has led to advancements in understanding malignancies such as mucosa-associated lymphoid tissue (MALT) lymphomas.
Latest Patents
Judith Dierlamm holds 2 patents that focus on the molecular characterization of chromosome translocation t(11;18)(q21;q21). Her patents include methods for determining whether a tissue sample contains cells with this specific chromosome translocation associated with various malignancies. The inventions provide insights into a novel mechanism of transformation of primary cells, involving the expression of a fusion proteinaceous molecule that includes apoptosis inhibitor 2 (API2) fused to other proteinaceous molecules. Additionally, her work introduces a novel nucleic acid sequence and a proteinaceous molecule known as the MALT-lymphoma associated Translocation (MLT) protein.
Career Highlights
Judith Dierlamm is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw, where she continues her research and innovation in biotechnology. Her expertise in molecular characterization has positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include Mathijs Baens and Peter Marijnen, who have collaborated with her on various research projects.
Conclusion
Judith Dierlamm's contributions to molecular characterization and her innovative patents have significantly advanced the understanding of chromosome translocations and their role in cancer. Her work continues to impact the field of biotechnology and cancer research.